CEFA - ETF AI Analysis
Top Page
Global X S&P Catholic Values Developed ex-US ETF (CEFA)
CEFA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 71.39M
- Region
- Developed Markets
- Expense Ratio
- 0.35%
- Beta
- 0.75
- Issuer
- Global X
- Inception Date
- Jun 22, 2020
- Dividend Yield
- 2.76%
- Asset Class
- Equity
- Index Tracked
- S&P Developed Ex-U.S. Catholic Values Index
CEFA Summary
CEFA is an ETF that follows the S&P Developed ex-U.S. Catholic Values Index, investing in large, well-known companies outside the United States while screening out businesses that conflict with Catholic values, such as weapons or tobacco. It holds global leaders like ASML Holding and Toyota Motor, giving investors broad international diversification across many countries and sectors. Someone might consider CEFA if they want long-term growth and global exposure while staying aligned with their ethical or religious beliefs. A key risk is that its value can rise or fall with international stock markets, and its ethical screens may limit certain opportunities.
How much will it cost me?
This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 invested. That’s a bit higher than the average low-cost index ETF because it tracks a specialized, values-based index rather than a plain-vanilla market benchmark.
What would affect this ETF?
Future performance of CEFA could benefit from steady growth in developed markets outside the U.S., especially if large international banks, industrial firms, and leading technology names like ASML and Siemens continue to do well and global trade remains healthy. On the other hand, rising interest rates, slower economic growth in Europe or Japan, energy price shocks affecting holdings like Shell, or regulatory changes impacting financials and healthcare companies could weigh on returns, while its values-based exclusions may also cause it to lag if restricted sectors outperform.
CEFA Top 10 Holdings
CEFA leans heavily on global blue chips, with ASML acting as both a powerhouse and a headache: its long-term run has been strong, but more recent trading has been choppy and is holding the fund back a bit. Financials like HSBC and Mitsubishi UFJ are more mixed, losing some steam lately after earlier gains. On the brighter side, health care name CSL and energy giant Shell are rising and helping to steady returns, while EssilorLuxottica and Toyota show a more uneven path. Overall, it’s a diversified, developed-markets ex-U.S. mix with notable exposure to Europe and Japan.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.23% | $2.30M | EUR 510.94B | 37.88% | 76Outperform | |
| CSL | ― | ― | ― | ― | 75Outperform | |
| Siemens | 1.73% | $1.23M | EUR 210.12B | 11.53% | 74Outperform | |
| EssilorLuxottica SA | 1.71% | $1.22M | EUR 87.56B | -39.31% | 68Neutral | |
| Shell (UK) | 1.63% | $1.16M | GBP 215.38B | 32.15% | 73Outperform | |
| HSBC Holdings | 1.66% | $1.18M | GBP 225.86B | 20.41% | 80Outperform | |
| HOYA | 1.41% | $1.01M | JPY 8.16T | -2.92% | 74Outperform | |
| Toyota Motor | 1.37% | $978.79K | JPY 35.86T | 16.22% | 80Outperform | |
| Mitsubishi UFJ Financial Group | 1.37% | $973.96K | JPY 37.82T | 50.35% | 76Outperform |
CEFA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CEFA, the sentiment is Negative. The current price of 39.24 is below the 20-day moving average (MA) of 39.81, below the 50-day MA of 40.42, and below the 200-day MA of 39.40, indicating a bearish trend. The MACD of -0.17 indicates Negative momentum. The RSI at 41.51 is Neutral, neither overbought nor oversold. The STOCH value of 26.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CEFA.
CEFA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $39.25 | $43.00(9.57% Upside) | $71.39M | 0.35% | 65Neutral | |
| $39.67 | $46.68(17.68% Upside) | $93.91M | 0.45% | 66Neutral | |
| $27.30 | $34.54(26.52% Upside) | $89.24M | 0.80% | 59Neutral | |
| $36.62 | $45.87(25.24% Upside) | $60.33M | 0.03% | 62Neutral | |
| $39.43 | $45.21(14.67% Upside) | $55.80M | 0.24% | 59Neutral | |
| $35.04 | $38.53(9.97% Upside) | $54.66M | 0.12% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CEFA | Global X S&P Catholic Values Developed ex-US ETF | 39.24 | 3.35 | 9.34% | |
| INEQ | Columbia International Equity Income Etf | 39.67 | 4.88 | 14.01% | |
| BCIL | Bancreek International Large Cap ETF | 27.30 | -0.25 | -0.91% | |
| DMXU | Xtrackers Bloomberg Developed Markets ex US Equity ETF | 36.62 | 2.75 | 8.12% | |
| DEEF | Xtrackers FTSE Developed ex US Multifactor ETF | 39.42 | 5.23 | 15.28% | |
| QLVD | FlexShares Developed Markets ex-US Quality Low Volatility Index Fund | 35.04 | 4.88 | 16.19% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.